Daiichi Sankyo forms partnership deals for DS-8201 trial
Daiichi Sankyo has collaborated with Merck and Pfizer for a Phase Ib clinical trial to investigate [fam-] trastuzumab deruxtecan (DS-8201)…
solid tumours Daiichi Sankyo Merck Pfizer
